Combination of biotransformation by P450 BM3 mutants with on-line post-column bioaffinity and mass spectrometric profiling as a novel strategy to diversify and characterize p38α kinase inhibitors.
V. Rea, D. Falck, J. Kool, F.J.J. de Kanter, J.N.M. Commandeur, N.P.E. Vermeulen, W.M.A. Niessen, M. Honing
Research output: Contribution to Journal › Article › Academic › peer-review
Fingerprint
Dive into the research topics of 'Combination of biotransformation by P450 BM3 mutants with on-line post-column bioaffinity and mass spectrometric profiling as a novel strategy to diversify and characterize p38α kinase inhibitors.'. Together they form a unique fingerprint.